Literature DB >> 51146

Casual blood-ethanol estimations in patients with chronic liver disease.

A N Hamlyn, A J Brown, S Sherlock, D N Baron.   

Abstract

Patients attending a clinic for diseases of the liver were tested for blood-ethanol by a gas chromatographic technique sensitive to about 5 mg/dl (1 mmol/1). Of 172 patients (51 men, 121 women) 36% gave a history of heavy drinking (greater than 80 g ethanol/day; equivalent to 8 fl oz of whisky or 1 litre of wine) and 13% had ethanol in the bloodstream at values of 8-400 mg/dl. 42 patients (24%) had the liver-biopsy changes of alcoholic liver disease, and 17 of these had ethanol in the blood at one time or another. Nearly half (22/49) of all patients admitting heavy drinking also had detectable blood-ethanol. In all cases but 1 where blood-ethanol was found, a drinking history was admitted on first attendance, and alcoholic liver disease was nearly always found on subsequent biopsy. Blood-ethanol and admission of drinking were most constantly found in association with alcoholic steatosis and hepatitis. Both features were less commonly present in cases of alcoholic cirrhosis. Only 1 patient of 22 with "cryptogenic" cirrhosis on biopsy was found to have both ethanol in the blood and an alcoholic history, although 5 had an alcoholic history alone. The value of serial blood-ethanol estimations in the treatment of alcoholics and the detection of relapses is demonstrated. The findings confirm the relatively low frequency of alcoholism as a contributor to cirrhosis in the United Kingdom. Alcohol does not seem a major cause of cryptogenic cirrhosis. Casual blood-ethanol estimation is a useful and objective adjunct to techniques of investigating diseases of the liver.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 51146     DOI: 10.1016/s0140-6736(75)92781-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  9 in total

1.  PCBP2 siRNA reverses the alcohol-induced pro-fibrogenic effects in hepatic stellate cells.

Authors:  Ravi S Shukla; Bin Qin; Yu-Jui Yvonne Wan; Kun Cheng
Journal:  Pharm Res       Date:  2011-06-04       Impact factor: 4.200

2.  S-adenosyl-methionine decreases ethanol-induced apoptosis in primary hepatocyte cultures by a c-Jun N-terminal kinase activity-independent mechanism.

Authors:  Maria del Pilar Cabrales-Romero; Lucrecia Márquez-Rosado; Samia Fattel-Fazenda; Cristina Trejo-Solís; Evelia Arce-Popoca; Leticia Alemán-Lazarini; Saúl Villa-Treviño
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

3.  Effect of ethanol on vascular prostacyclin (prostaglandin I2) synthesis, platelet aggregation, and platelet thromboxane release.

Authors:  D P Mikhailidis; J Y Jeremy; M A Barradas; N Green; P Dandona
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-19

Review 4.  Clinical pathology of alcohol.

Authors:  V Marks
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

Review 5.  Early identification of alcohol abuse: 2: Clinical and laboratory indicators.

Authors:  S Holt; H A Skinner; Y Israel
Journal:  Can Med Assoc J       Date:  1981-05-15       Impact factor: 8.262

6.  Ethanol inhibits asialoglycoprotein receptor synthesis but augments its mRNA expression in a human hepatoma cell line.

Authors:  Y Kohgo; Y Mogi; J Kato; R Nakaya; M Nakajima; S Katsuki; Y Niitsu
Journal:  J Gastroenterol       Date:  1994-10       Impact factor: 7.527

7.  Sex-related differences among 100 patients with alcoholic liver disease.

Authors:  M Y Morgan; S Sherlock
Journal:  Br Med J       Date:  1977-04-09

8.  Ethanol upregulates NMDA receptor subunit gene expression in human embryonic stem cell-derived cortical neurons.

Authors:  Yangfei Xiang; Kun-Yong Kim; Joel Gelernter; In-Hyun Park; Huiping Zhang
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

9.  Maternal Ethanol Exposure Acutely Elevates Src Family Kinase Activity in the Fetal Cortex.

Authors:  Dandan Wang; Brian W Howell; Eric C Olson
Journal:  Mol Neurobiol       Date:  2021-07-16       Impact factor: 5.590

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.